View Clinical Trial (Medical Research Study)

Droperidol Versus Metoclopramide for the Treatment of Primary Headaches in the Emergency Department: A Prospective Randomized, Double-blinded Trial.

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

---

Conditions:		Primary Headaches (Includes Migraines, Tension, Cluster Headaches)
Purpose:		The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.
Study Summary:
Criteria:		Inclusion Criteria: - 18 years old to 65 years old, diagnosis of primary headache Exclusion Criteria: - Allergy to study medications, pregnant, breast-feeding, prisoners, non-english speaking, not eligible to receive droperidol based on ED protocol (see below), patients in whom head trauma, infection, vascular disorders, and disorders of facial or cranial structures are suspected ED Droperidol Protocol Droperidol must NOT be used in patients with any of the following: - Known or suspected QT prolongation, including congenital long QT syndrome - Cardiac Disease [cardiomyopathy, congestive heart failure, hypertension, ischemic heart disease, myocardial infarction, bradycardia (< 50 bpm)] - History of the following: - Renal failure - Cerebrovascular disease - Diabetes or hypoglycemia - Alcoholism/alcohol abuse - Pituitary insufficiency - Hypothyroidism - Hypothermia - Anorexia - Advanced age (>65 yrs) - Use of the following medications: digoxin, benzodiazepine, diuretics, IV opiates, or other medications known to prolong the QTc interval.
NCT ID:		NCT01406860
Primary Contact:		Principal Investigator Jon Van Heukelom, MD University of Iowa
Backup Contact:		N/A
Location Contact:		Iowa City, Iowa 52242 United States There is no listed contact information for this specific location. Site Status: N/A

---

---